# DFN-11 Injection in Episodic Migraine With or Without Aura

> **NCT02569853** · PHASE3 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 268 (actual)

## Conditions studied

- Episodic Migraine

## Interventions

- **DRUG:** DFN-11
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02569853
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-21
- **Primary completion:** 2017-05-30
- **Final completion:** 2018-02-26
- **Target enrollment:** 268 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02569853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02569853, "DFN-11 Injection in Episodic Migraine With or Without Aura". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02569853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*